- Oct 30, 2026
- 11
- 0
- 1
Walk into any clinic promising TRT and they hand you a blood panel with ranges. Look closely at those ranges. They were calculated from populations of healthy young men not receiving exogenous testosterone, often including older patients with hypogonadism mixed in. Your lab report says normal means somewhere between seven and twenty five nanograms per deciliter, depending on the assay. But normal for whom.
The clinical literature distinguishes several targets. One target restores physiological function without suppression of the hypothalamic pituitary axis. Another target maintains levels in the upper physiological range while acknowledging gonadotropin suppression. A third target pushes supraphysiological for performance outcomes. None of these are identical, and most clinicians who advertise TRT blend them together because explaining three different strategies takes time insurance will not reimburse.
You get prescribed a dose that lands you in the middle of the reference range, you feel fine initially, then after six months something drifts. Hematocrit creeps up. Estradiol shifts. Sleep quality changes. Mood fluctuates. Nobody adjusts the protocol because all your labs stay inside the green boxes on the report. The ranges were never calibrated for the patient who stays on therapy indefinitely rather than using it as a diagnostic trial.
The question most clinics avoid. When your provider says your levels are optimal, are they optimal for restoration of natural function, for sustained therapeutic maintenance, or for whatever outcome you personally want but never wrote down on the intake form. Who here has ever asked that distinction before signing the consent paperwork.
The clinical literature distinguishes several targets. One target restores physiological function without suppression of the hypothalamic pituitary axis. Another target maintains levels in the upper physiological range while acknowledging gonadotropin suppression. A third target pushes supraphysiological for performance outcomes. None of these are identical, and most clinicians who advertise TRT blend them together because explaining three different strategies takes time insurance will not reimburse.
You get prescribed a dose that lands you in the middle of the reference range, you feel fine initially, then after six months something drifts. Hematocrit creeps up. Estradiol shifts. Sleep quality changes. Mood fluctuates. Nobody adjusts the protocol because all your labs stay inside the green boxes on the report. The ranges were never calibrated for the patient who stays on therapy indefinitely rather than using it as a diagnostic trial.
The question most clinics avoid. When your provider says your levels are optimal, are they optimal for restoration of natural function, for sustained therapeutic maintenance, or for whatever outcome you personally want but never wrote down on the intake form. Who here has ever asked that distinction before signing the consent paperwork.